Италияда қуықты алып тастау және қалпына келтіруге бойынша ең жақсы дәрігерлер – ТОП-2 дәрігер

After graduating in Medicine and Surgery, Dr. Saltutti specialized in Urology, gaining advanced expertise in treating disorders of the male and female urinary system, as well as the male reproductive system. Throughout his professional journey, he has focused on innovative and minimally invasive surgical techniques, such as robotic and laparoscopic surgery, especially for the treatment of prostate, kidney, and bladder cancers.

Over the years, Dr. Saltutti has attended numerous national and international conferences, expanding his knowledge and contributing to the advancement of therapeutic and surgical techniques in the urological field. He is known for his clinical expertise and dedication to his patients, adopting a personalized approach to each case to ensure effective, high-quality care.

His work at GVM facilities, which boast cutting-edge technologies and a highly qualified medical team, allows Dr. Saltutti to offer comprehensive services ranging from early diagnosis to treatment and post-operative rehabilitation. His areas of specialization include, in addition to urological cancers, the treatment of prostate conditions, kidney stones, urinary incontinence, and male sexual dysfunction.

Thanks to his experience and passion for the medical profession, Dr. Carlo Saltutti is a reference point for patients seeking excellent urological care at the GVM group

Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.

Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.

He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.